SOUTH JORDAN, Utah - Merit Medical Systems , Inc. (NASDAQ: NASDAQ:MMSI), a company specializing in healthcare technology, has announced the commercial release of its Micro ACE Advanced Micro-Access System, following clearance from the U.S. Food and Drug Administration (FDA). The system represents the latest addition to the Merit Vascular portfolio, which includes devices for percutaneous access and closure during interventional procedures.
The Micro ACE system is engineered to provide micro-access across various vascular anatomies, a critical step in procedures aimed at diagnosing and treating narrowed blood vessels due to atherosclerosis. Atherosclerosis, an inflammatory condition characterized by plaque buildup in arteries, is associated with diseases like coronary and peripheral artery disease, leading causes of death in the United States.
Merit's new device offers a balance of stiffness and resiliency, boasting twice the resistance to kinking and compression compared to its leading competitor. It is also reported to be 9% stiffer than the standard micro-introducer in the market. Notably, the Micro ACE features a distinct marker tip design that enhances visibility under fluoroscopy by nine times, facilitating accurate positioning at the beginning of a procedure.
In addition to the U.S. market, Merit plans to seek CE mark designation for the Micro ACE system, which would allow for its use in European countries. The company is also in the process of securing patents for the Micro ACE technology both domestically and internationally.
Fred P. Lampropoulos, Chairman and CEO of Merit, expressed the company's commitment to improving patient care through innovations like the Micro ACE, which leverages their experience in reinforced sheath design to enhance common vascular access procedures.
Founded in 1987, Merit Medical Systems, Inc. has a global presence, employing approximately 7,000 people and catering to hospitals worldwide through its extensive sales and clinical support team.
This announcement is based on a press release statement from Merit Medical Systems, Inc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.